Skip to content


  • Poster presentation
  • Open Access

PReS-FINAL-2221: An earliest diagnosis of FMF

  • 1,
  • 1,
  • 1,
  • 1,
  • 1 and
  • 1
Pediatric Rheumatology201311 (Suppl 2) :P211

  • Published:


  • Meningitis
  • Colchicine
  • Mutation Analysis
  • Familial Mediterranean Fever
  • Ankle Joint


Familial Mediterranean fever (FMF) is an autosomal recessive disease, mainly affecting Jews, Armenians, Turks, Arabs and other groups living around Mediterranean basin. Major symptoms of disease are recurrent periodic fever accompained by serositis. The disease is usually diagnosed at ages less than 20 years. Onset of the disease atolder age can rarely occur. Symptoms related to FMF are noted when children become more verbal, usually after 2 years of age. Mutation analysis supports diagnostic evaluation.


Here, we are reporting the youngest FMF patient, that were internalized after birth as sepsis. Physicians were unable to discharge her from the hospital due to high acute phase response, that was dedicated to meningitis, urinary tract infection, sepsis and so on. Her metabolic screenings were done and were found to be negative. She was consulted to pediatric rheumatology for the high acute phase response and fever. With a detailed history and evaluation, it was learned that her mother had recurrent swelling of her ankle joints. Mutation analysis was performed and two homozygous mutations (M694V andR202Q) were identified. She was diagnosed as FMF at 3 months of age and colchicine was started with a dose of 0.25 mg/day. She responded to colchicine both clinically and in laboratory basis. Her uncontrolled acute phase response declined gradually.


This case was reported to point out the importance of early remembrance of possible autoinflammatory diseases even at very early ages especially at endemic countries.

Disclosure of interest

None declared.

Authors’ Affiliations

Kanuni Sultan Suleyman Education and Research Hospital, Istanbul, Turkey


© Keskindemirci et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.